Spots Global Cancer Trial Database for Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation

Official Title: A Prospective Study to Evaluate the Incidence and Patterns of Nausea and Vomiting in Patients Receiving Combined Chemotherapy and Radiation

Study ID: NCT00716157

Conditions

Cancer of the Head and Neck

Cancer of the Lung

Cancer of the Esophagus

Gastro-esophageal Junction Cancer

Interventions

Study Description

Brief Summary: Questionnaire study to observe the incidence and pattern or nausea and vomiting in patients receiving combined chemotherapy and radiation. 83% of patients experience radiation therapy-induced vomiting; significant nausea and vomiting could develop with concurrent chemotherapy despite standard anti-nauseous medication prophylaxis.

Detailed Description: Questionnaires will be answered daily on a weekly basis during period of radiation and chemotherapy.